Arkin Bioholdings

Arkin Bio is the life sciences investment arm of Arkin Capital, focused on backing biotech companies from early-stage venture through later-stage crossover investing. The group operates through vehicles including Arkin Bio Ventures and Arkin Bio Capital, investing in pre-clinical, clinical-stage, and pre-IPO biotech companies. It is not a drug-development operating biotech company itself, but rather a healthcare-focused investment organization with deep scientific diligence capabilities and a global biotech network. Arkin Bio emphasizes transformative therapies in areas of unmet medical need and has supported a portfolio spanning private and public biotechnology companies. The broader Arkin platform reports more than $2 billion under management across multiple strategies, with healthcare as a core area of expertise.